Patent directory · USPTO A61K / A61P
Patents matching “BrightGene Bio-Medical Technology Co., Ltd.”
9 pharma patents match "BrightGene Bio-Medical Technology Co., Ltd." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 9 pharmaceutical patents matching "BrightGene Bio-Medical Technology Co., Ltd." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted -
US 11191843
Multi-arm targeting anti-cancer conjugate
granted -
US 11179467
Exenatide modifier and use thereof
granted -
US 10869863
Multi-arm polymeric targeting anti-cancer conjugate
granted -
US 10759905
Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application of biodegradable amphiphilic polymer in preparation of medicines for targeted therapy of lung cancer
granted -
US 10689413
Composition enriched in single isomer of NUC-1031 and preparation method and use thereof
granted -
US 10292940
Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof
granted -
US 9796728
Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof
granted -
US 8507463
Nucleotide analogue prodrug and the preparation thereof
granted